Recent Finacing
Recent Raise
SonALAsense develops SONALA-001, an MR-guided focused ultrasound drug-device sonodynamic therapy, and conducts Phase 0/1–2 clinical trials targeting diffuse intrinsic pontine glioma, recurrent glioblastoma, and high-grade gliomas.
